GlaxoSmithKline (GSK) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for GlaxoSmithKline (GSK) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$95.296B||$37.820B|
|GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.|